Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antibiotic therapy for pelvic inflammatory disease.

J G Pastorek1

  • 1Department of Obstetrics and Gynecology, Louisiana State University Medical Center, New Orleans 70112-2822.

The Journal of Reproductive Medicine
|March 1, 1990
PubMed
Summary

Pelvic inflammatory disease (PID) treatment is evolving. New antibiotic combinations offer effective single-agent regimens for this serious sexually transmitted infection, potentially simplifying care for young women.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Addressing obesity in medical practice: is weight loss medically beneficial?

Medscape women's health·2000
Same author

Perspective on women's health: editors' 1997-1998 year in review.

Medscape women's health·1998
Same author

Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group.

Sexually transmitted diseases·1997
Same author

Tuberculosis skin testing in pregnancy: trends in a population.

Journal of perinatology : official journal of the California Perinatal Association·1997
Same author

Elective versus emergency cesarean hysterectomy on a teaching service--1981 to 1991.

Southern medical journal·1997
Same author

Clinical and microbiological correlates of vaginal trichomoniasis during pregnancy. The Vaginal Infections and Prematurity Study Group.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·1996

Area of Science:

  • Gynecology
  • Infectious Diseases
  • Pharmacology

Background:

  • Pelvic inflammatory disease (PID) is a significant health concern, particularly for young women, leading to substantial morbidity.
  • Current treatment guidelines recommend aggressive hospitalization and parenteral antimicrobial therapy for PID.
  • Established antibiotic regimens include cephalosporins with doxycycline or clindamycin with an aminoglycoside.

Purpose of the Study:

  • To evaluate the efficacy of newer antibiotic options for treating pelvic inflammatory disease (PID).
  • To explore the potential of single-agent antibiotic regimens in PID management.
  • To assess the role of beta-lactam/beta-lactamase-inhibitor combinations in treating PID.

Main Methods:

  • Review of current treatment recommendations for PID.
  • Analysis of the antimicrobial spectrum of beta-lactam/beta-lactamase-inhibitor combinations.
  • Comparison of single-agent regimens with traditional multi-drug therapies for PID.

Main Results:

  • Beta-lactam/beta-lactamase-inhibitor combinations demonstrate broad-spectrum activity against key PID pathogens.
  • These newer agents exhibit activity against penicillinase-producing Neisseria gonorrhoeae, aerobic, and anaerobic bacteria.
  • Single-agent regimens using these combinations are now a viable option for PID treatment.

Conclusions:

  • The availability of beta-lactam/beta-lactamase-inhibitor combinations simplifies PID antibiotic therapy.
  • Single-agent regimens offer an effective alternative to traditional multi-drug approaches for PID.
  • Gynecologists can utilize these advancements to manage this serious sexually transmitted infection.

Related Experiment Videos